Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet scientists have struggled to identify consistent brain markers that could improve ...

Major depressive disorder (MDD) is a debilitating condition that affects more than 246 million people worldwide, yet ...

The American College of Lifestyle Medicine has published a new expert consensus statement affirming evidence-based lifestyle interventions as foundational, primary, and adjunctive treatments for major ...

Patients with asthma and major depressive disorder had more negative beliefs about their asthma, worse treatment adherence ...

Patients with depressive symptoms and asthma had elevated levels of serum brain-derived neurotrophic factor in association ...

In older adults with asthma, major depressive disorder was linked to poorer control and quality of life, partly via negative ...

Clinical data further supports the effectiveness of EXOMIND. In a recent IRB-approved clinical trial, 83% of patients diagnosed with depression reported feeling less depressed three months after their ...

A new medical large language model (LLM) achieved over 91% accuracy in identifying female participants diagnosed with major depressive disorder after analyzing a short WhatsApp audio recording where ...

Patients who experienced a formulary-related rejection of cariprazine for adjunctive treatment of major depressive disorder had significantly higher hospitalization rates than those with approved ...